The global contraceptive market is estimated to grow at 4.3% during 2015-2022 and is estimated to be $32.85 billion by 2022. Increasing prevalence of sexually transmitted diseases and growing need for population control. The global contraceptive market is majorly driven by various factors such as growing prevalence of sexually transmitted infections (STIs), such as HIV. The introduction of new products, exhibiting improved efficacy are expected to drive the contraceptive market over the forecast period.

The global ophthalmic drugs market is expected to grow at a CAGR of 7% during 2015-2022 and is estimated to be approximately $XX billion at the end of the forecasted period i.e. by 2022. The market is driven by various factors which include increase prevalence of eye related disorders such as glaucoma and cataract aging population, regulatory approvals to new drugs and devices, new technologies such as focus on combining drugs and device therapies and increasing economic factors such as rise in disposable income and health expenditure in emerging countries such as India and China.